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Obstructive apneas produce high negative intrathoracic pressure which imposes an afterload burden on 
the left ventricle.  Such episodes might produce structural changes in the left ventricle over time.  
Doppler echocardiograms were obtained within 2 months of attended polysomnography.  Patients were 
grouped according to apnea-hypopnea index (AHI): mild/no OSA (AHI < 15) and mod/severe OSA (AHI ≥ 
15).  Mitral valve tenting height and area, left ventricular (LV) long and short axis, and LV end-diastolic 
volume (LVEDV), were measured along with tissue Doppler parameters.   Comparisons of measurements 
at baseline and follow up between and within groups were obtained; correlations between absolute 
changes (deltas) in echocardiographic parameters were also performed.  After a mean follow up of 240 
days mitral valve tenting height increased significantly (1.17 ± 0.12 cm to 1.28 ± 0.17 cm, p=0.001) in 
mod/severe OSA as did tenting area (2.30 ± 0.41 cm2 to 2.66 ± 0.60 cm2, p=0.0002); delta tenting height 
correlated with delta LVEDV (rho 0.43, p=0.01) and delta tenting area (rho 0.35, p=0.04).  In mild/no OSA 
patients there was no significant change in tenting height; there was a borderline significant increase in 
tenting area (2.20 ± 0.44 cm2 to 2.31 ± 0.43 cm2, p=0.05).  Septal E’ decreased (8.04 ± 2.49 cm/sec to 
7.10 ± 1.83 cm/sec, p=0.005) in mod/severe OSA subjects, but not in the mild/no OSA group.  In 
conclusion, in patients with mod/severe OSA, mitral valve tenting height and tenting area increase 
significantly over time.  This appears to be related, at least in part, to changes in LV geometry. 
 
Running Head:  OSA increases mitral valve tenting 
 
Key Words:  Mitral valve tenting, obstructive sleep apnea, left ventricular geometry 
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Introduction 
Obstructive sleep apnea (OSA) has adverse effects on left ventricular (LV) diastolic function 1 
and on global LV function 2-4 .  However, aside from producing increased wall thickness 2  there is little 
information available regarding effects on left heart structure.  We tested the hypothesis that moderate 
to severe OSA, over time, can lead to changes in mitral valve tenting height and area in association with 




This prospective longitudinal study recruited subjects from the Sleep Disorders Center at Albert 
Einstein Medical Center between January 2008 and May 2010.  All had sleep tests ordered on clinical 
grounds and none had a previously diagnosed sleep disorder.  Exclusions included 1) any evidence of 
coronary disease, 2) mitral leaflet disease, and 3) decreased ejection fraction for any reason.  
Demographic and clinical data were collected but no attempt was made to control medical therapy.  
Subjects underwent Doppler echocardiography shortly after polysomnography and again 6 months or 
more after the initial study.  For those prescribed continuous positive airway pressure, compliance was 
measured by interrogation of the device or “smartcard”.  Because only 4 subjects were compliant (> 4 
hours/night), the current paper reflects the natural history of untreated severe OSA. 
Polysomnography was performed utilizing the VIASYS SomnoStar Pro Sleep System (SomnoStar 
Software 9-1b).  The electroencephalogram, electro-oculogram, and electromyogram were monitored 
for sleep staging.  Nasal pressure monitoring, chest wall movement, abdominal movement, snoring and 
oxygen saturation were recorded for respiratory assessment.  The electrocardiogram and tibial 
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electromyogram were monitored for cardiac arrhythmias and nocturnal limb movements respectively.  
Studies were interpreted according to the standards of the American Academy of Sleep Medicine5.  
Presence and severity of OSA were established based on apnea-hypopnea index (AHI) : <5 = no OSA, ≥ 5 
AHI < 15 = mild OSA, ≥ 15 AHI < 30 = moderate OSA, and AHI≥ 30 = severe OSA.  Interpretation of all 
polysomnograms was performed by board certified sleep medicine physicians.  
 
 Two-dimensional and Doppler echocardiography were performed according to American Society 
of Echocardiography standards 6.  Mitral valve tenting area was measured in mid-systole in the 
parasternal long-axis view as the area bounded by the closed mitral leaflets and a line connecting the 
annular attachment points of the 2 leaflets.  Tenting height was defined as the distance from that line to 
the point of coaptation of the leaflets7 (figure 1).  Left atrial dimension was measured as the diameter of 
the left atrium in systole in the parasternal long-axis view.  Left atrial volume was measured in the apical 
views according to the biplane area-length method.  The LV long axis was measured at end-diastole from 
the annular plane to the apex in the 4-chamber view.  The LV short axis was measured in the same view 
as the diameter of the left ventricle (endocardium to endocardium) at the tips of the open mitral valve 
leaflets.  LV end diastolic volume (LVEDV) and end systolic volume (LVESV) were measured using the 
modified Simpson’s biplane method.  The interpapillary muscle distance of the left ventricle was 
measured at end-diastole in the parasternal short axis view by drawing a line through the papillary 
muscles and measuring between the LV endocardial borders where the papillary muscles attached.  
Tissue Doppler measurements included the systolic wave (S’) and early diastolic wave (E’) measured at 
the septal and lateral aspects of the mitral valve annulus in the 4-chamber view.   
 
Two experienced, board certified echocardiographers (GSP and VMF) read all the 
echocardiograms.  In order to avoid interobserver variability, each parameter was measured by only one 
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observer (GSP: tenting height, tenting area, LVEDV, LVESV, left atrial dimension, left atrial volume; VMF: 
LV long axis, LV short axis, LV interpapillary muscle distance, E’, and S’).  Values for each measured 
parameter were obtained by averaging a minimum of 3 measurements for that parameter.  
Echocardiograms were read in a blinded manner without knowledge of OSA status.   
 
Continuous variables are displayed as mean ± standard deviation and categorical variables are 
displayed as numbers and percentages.  Paired analyses were used to compare variables within groups 
over time.  Non-parametric correlations (Spearman) were used to assess the relationship between 
absolute changes (deltas) in echocardiographic variables over time in both groups.  Two-tailed p values < 
0.05 were considered significant in advance.  Linear regression was used to assess for univariate 
predictors of change in tenting height and tenting area; those variables with p values < 0.10 were 
included in multivariate analysis.  Multivariate linear regression was used to assess for predictors of 
change in tenting height and area after adjustment for variables identified in the univariate analyses; p 
values < 0.05 were considered significant.  Intraobserver variability was calculated for tenting height and 




Fifty-four subjects were enrolled and followed for a mean of 240 days (range 180 - 431). Six 
patients did not have follow-up echocardiograms (11% of the sample).  Baseline characteristics of the 
subjects included in the study are displayed in table 1.     
 
Page 7 of 14 
 
When divided into 2 groups, AHI < 15 (mild/no OSA) and AHI ≥ 15 (mod/severe OSA), baseline 
characteristics were similar between groups except for BMI which was higher in the group with 
moderate to severe OSA.   
 
Intraobserver variability for the main outcome variables was 4% for tenting height and 6% for 
tenting area.  Baseline Doppler echocardiographic variables for the 2 AHI groups are presented in table 
2.  Only lateral E’ differed significantly between groups (p = 0.05).  Table 3 presents Doppler 
echocardiographic variables over time stratified by AHI groups.  Of note, among those with mod/severe 
OSA, tenting height increased over time (p = 0.001; figure 2a) as did tenting area (p = 0.0002; figure 2b).  
In the group with mild/no OSA there was no significant change in tenting height while a borderline 
significant increase in tenting area (p = 0.05) was observed.  Septal E’ decreased significantly among 
mod/severe OSA, with no significant change noted in those with mild/no OSA. 
 
We also performed correlations within the 2 AHI groups to test whether changes in tenting 
height and tenting area were dependent on changes in LV geometry.  No significant correlations were 
found in the mild/no OSA group.  However, among mod/severe OSA subjects, delta tenting height had a 
positive and significant correlation with delta LV long axis (rho 0.39, p=0.02), delta LV short axis (rho 
0.36, p=0.03), and delta LVEDV (rho 0.43, p=0.01; figure 3).  A positive and significant correlation 
between delta tenting area and delta LVEDV (rho 0.35, p=0.04) was also observed; however, delta LV 
long axis and delta LV short axis showed nonsignificant, though positive, correlations.   
 
Linear regression analysis assessing for univariate predictors of change in tenting height showed 
only AHI to be a significant predictor (F ratio 3.83, p = 0.05).  Furthermore, AHI remained a significant 
predictor of tenting height on multivariate analysis (F ratio 3.93, p = 0.04) after adjustment for age, 
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gender, race, BMI and hypertension.  No significant predictors were found for tenting area (p > 0.10 for 
each variable).  
 
It should be noted that, despite changes in tenting height an area over time, no subject 





The main finding of this study is that tenting height and tenting area increased significantly over 
time in patients with moderate to severe OSA.  This appeared to be related, in part, to remodeling of the 
left ventricle.  Obstructive apneas impose an afterload burden on the heart8-10  and can occur hundreds 
of times per night.  The cumulative effects of this pathophysiology, over months to years, might account 
for changes in mitral valve tenting and LV chamber dimensions.   
 
It is generally accepted that changes in ventricular shape can produce changes in tenting height 
and tenting area.  In disease states that produce LV dilation, tenting is associated with outward and 
apical displacement of the papillary muscles and often produces clinically significant mitral regurgitation 
7,11,12.  In this setting, the ventricle assumes a more spherical shape.  Changes in LV geometry are also 
commonly seen in athletes although associated mitral regurgitation has not been reported.  As opposed 
to disease states, ventricular shape appears to be maintained in athletes though chamber dimensions 
increase 13-16.  The current data suggest similar changes in LV geometry in patients with moderate to 
severe OSA.  
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  The finding that OSA increases mitral valve tenting is potentially important in several ways.  
While none of our subjects developed clinically significant mitral regurgitation, it is conceivable that 
such might develop over a longer time period.  The current study excluded subjects with dilated 
ventricles and associated mitral regurgitation.  It may be that OSA worsens pre-existing mitral 
regurgitation by increasing tenting.  It is also possible that significant mitral regurgitation only occurs 
during obstructive episodes when blood pressure and afterload are high.  Our group has shown that 
following an apneic episode (simulated by the Mueller maneuver), there is a compensatory increase in 
blood flow to the left side of the heart, which could augment transient mitral regurgitation. 9  In fact, 
most episodes of acute pulmonary edema, where mitral regurgitation may be an important contributing 
factor, occur at night.   
 
Few previous studies have looked at effects of OSA on LV geometry.  Nearly all are observational 
and cross-sectional in nature.  Dursunoglu et al measured end diastolic dimension by M-mode 
echocardiography in 67 subjects with OSA who had no cardiac disease 17.  They found a non-significant 
trend towards higher values as AHI increased.  Drager et al studied 60 patients with hypertension and/or 
OSA in whom other disorders were carefully excluded 18.  Comparing normotensive subjects with OSA to 
controls, they found no significant difference in LV end diastolic dimension between groups.  However, 
in another study of OSA and hypertension, Myslinski et al observed significantly higher values of LV end 
diastolic dimension in OSA subjects with adequately treated hypertension when compared with controls 
19 . 
 
In addition to changes in mitral valve tenting, this study documented a decrease over time in the 
tissue Doppler parameter E’ among those with moderate to severe OSA.  This is consistent with previous 
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reports 1,2,20.  It is important as decreased E’ is a marker of worsening of global LV diastolic function, 
which in turn is associated with heart failure, pulmonary hypertension, and atrial fibrillation.   
 
This study involved a small number of patients and the findings need to be reproduced in a 
larger sample.  None of the subjects developed significant mitral regurgitation and any connection 
between LV remodeling, tenting height and area, and development of future mitral regurgitation 
remains speculative.  However, increases in tenting height and area have been strongly associated with 
mitral regurgitation in diseased ventricles.  In addition, these studies were carried out in conscious 
subjects.  It is possible that mitral regurgitation occurs during an obstructive apnea but not in the waking 
state.  One of the limitations of OSA research generally, is the difficulty in imaging the heart during an 
obstructive apnea.  
 
Our study sample was largely minority and thus our findings might not apply to the general 
population.  However, there is no reason to believe that the findings would vary by race or ethnicity.  
More likely, they are the result of the physiologic perturbations associated with obstructive sleep apnea. 
 
The major strengths of this study are its prospective nature and the blinded interpretation of 
the echocardiograms.  In addition, the increases in mitral valve tenting height and tenting area were 
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Figure  Legends 
 
Figure 1.  Parasternal long axis view in midsystole.  The mitral valve tenting area is measured by 
drawing a line connecting the annular attachment points of the mitral leaflets and then tracing the 
leaflet borders.  In this case the tenting area is 2.1 cm2 (measurement algorithm also indicates the length 
of the border, 8.0 cm).  The tenting height is measured by drawing a perpendicular line from the annular 
line to the point of leaflet coaptation, in this case 1.3 cm. 
Figure 2.  Mitral valve tenting height (2a) and tenting area (2b) at baseline and at follow-up in the 
mild/no OSA and mod/severe OSA groups.  Both variables are seen to increase significantly over time in 
the mod/severe OSA group. 
Figure 3.  Scatterplot of change in mitral valve tenting height as a function of change in left ventricular 
end diastolic volume (biplane modified Simpson’s method).  Rho = 0.42 indicating a good correlation and 
suggesting that change in left ventricular end diastolic volume accounts for at least some of the change 
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